Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Long‐term safety of botulinum toxin type A

Identifieur interne : 004132 ( Istex/Corpus ); précédent : 004131; suivant : 004133

Long‐term safety of botulinum toxin type A

Auteurs : Markus Naumann ; A. Peter Moore

Source :

RBID : ISTEX:C21BADE2AD5AFC9C2C60103AF192D2D33091F69C
Url:
DOI: 10.1002/mds.10495

Links to Exploration step

ISTEX:C21BADE2AD5AFC9C2C60103AF192D2D33091F69C

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Long‐term safety of botulinum toxin type A</title>
<author>
<name sortKey="Naumann, Markus" sort="Naumann, Markus" uniqKey="Naumann M" first="Markus" last="Naumann">Markus Naumann</name>
<affiliation>
<mods:affiliation>Department of Neurology University of Würzburg Würzburg, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Moore, A Peter" sort="Moore, A Peter" uniqKey="Moore A" first="A. Peter" last="Moore">A. Peter Moore</name>
<affiliation>
<mods:affiliation>Department of Neuroscience Liverpool University Liverpool, United Kingdom</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C21BADE2AD5AFC9C2C60103AF192D2D33091F69C</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/mds.10495</idno>
<idno type="url">https://api.istex.fr/document/C21BADE2AD5AFC9C2C60103AF192D2D33091F69C/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">004132</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Long‐term safety of botulinum toxin type A</title>
<author>
<name sortKey="Naumann, Markus" sort="Naumann, Markus" uniqKey="Naumann M" first="Markus" last="Naumann">Markus Naumann</name>
<affiliation>
<mods:affiliation>Department of Neurology University of Würzburg Würzburg, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Moore, A Peter" sort="Moore, A Peter" uniqKey="Moore A" first="A. Peter" last="Moore">A. Peter Moore</name>
<affiliation>
<mods:affiliation>Department of Neuroscience Liverpool University Liverpool, United Kingdom</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2003-09">2003-09</date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="1080">1080</biblScope>
<biblScope unit="page" to="1081">1081</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C21BADE2AD5AFC9C2C60103AF192D2D33091F69C</idno>
<idno type="DOI">10.1002/mds.10495</idno>
<idno type="ArticleID">MDS10495</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>Markus Naumann MD</name>
<affiliations>
<json:string>Department of Neurology University of Würzburg Würzburg, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>A. Peter Moore MD, FRCP</name>
<affiliations>
<json:string>Department of Neuroscience Liverpool University Liverpool, United Kingdom</json:string>
</affiliations>
</json:item>
</author>
<genre>
<json:string>Serial article</json:string>
</genre>
<host>
<volume>18</volume>
<pages>
<total>2</total>
<last>1081</last>
<first>1080</first>
</pages>
<issn>
<json:string>0885-3185</json:string>
</issn>
<issue>9</issue>
<subject>
<json:item>
<value>Letter to the Editor</value>
</json:item>
</subject>
<genre></genre>
<language>
<json:string>unknown</json:string>
</language>
<title>Movement Disorders</title>
<doi>
<json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<language>
<json:string>eng</json:string>
</language>
<qualityIndicators>
<score>1.045</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 810 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<abstractCharCount>0</abstractCharCount>
<pdfWordCount>995</pdfWordCount>
<pdfCharCount>6260</pdfCharCount>
<pdfPageCount>2</pdfPageCount>
<abstractWordCount>0</abstractWordCount>
</qualityIndicators>
<title>Long‐term safety of botulinum toxin type A</title>
<publicationDate>2003</publicationDate>
<copyrightDate>2003</copyrightDate>
<doi>
<json:string>10.1002/mds.10495</json:string>
</doi>
<id>C21BADE2AD5AFC9C2C60103AF192D2D33091F69C</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/C21BADE2AD5AFC9C2C60103AF192D2D33091F69C/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/C21BADE2AD5AFC9C2C60103AF192D2D33091F69C/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/C21BADE2AD5AFC9C2C60103AF192D2D33091F69C/fulltext/tei">
<teiHeader type="text">
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Long‐term safety of botulinum toxin type A</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability>
<p>Wiley Subscription Services, Inc., A Wiley Company</p>
</availability>
<date>2003</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Long‐term safety of botulinum toxin type A</title>
<author>
<persName>
<forename type="first">Markus</forename>
<surname>Naumann</surname>
<roleName type="degree">MD</roleName>
</persName>
<note type="correspondence">
<p>Correspondence: Department of Neurology, University of Würzburg, Josef‐Schneider‐Str. 11, 97080 Würzburg, Germany</p>
</note>
<affiliation>Department of Neurology University of Würzburg Würzburg, Germany</affiliation>
</author>
<author>
<persName>
<forename type="first">A. Peter</forename>
<surname>Moore</surname>
<roleName type="degree">MD, FRCP</roleName>
</persName>
<affiliation>Department of Neuroscience Liverpool University Liverpool, United Kingdom</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2003-09"></date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="1080">1080</biblScope>
<biblScope unit="page" to="1081">1081</biblScope>
</imprint>
</monogr>
<idno type="istex">C21BADE2AD5AFC9C2C60103AF192D2D33091F69C</idno>
<idno type="DOI">10.1002/mds.10495</idno>
<idno type="ArticleID">MDS10495</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2003</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>Article category</head>
<item>
<term>Letter to the Editor</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2003-02-04">Received</change>
<change when="2003-02-28">Registration</change>
<change when="2003-09">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/C21BADE2AD5AFC9C2C60103AF192D2D33091F69C/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup>
<id type="product" value="MDS"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="subtitle">Official Journal of the Movement Disorder Society</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="90">
<doi origin="wiley" registered="yes">10.1002/mds.v18:9</doi>
<numberingGroup>
<numbering type="journalVolume" number="18">18</numbering>
<numbering type="journalIssue">9</numbering>
</numberingGroup>
<coverDate startDate="2003-09">September 2003</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="letter" position="240" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/mds.10495</doi>
<idGroup>
<id type="unit" value="MDS10495"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="2"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Letter to the Editor</title>
<title type="tocHeading1">Letters to the Editor</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2003 Movement Disorder Society</copyright>
<eventGroup>
<event type="manuscriptReceived" date="2003-02-04"></event>
<event type="manuscriptAccepted" date="2003-02-28"></event>
<event type="publishedOnlineEarlyUnpaginated" date="2003-05-29"></event>
<event type="firstOnline" date="2003-05-29"></event>
<event type="publishedOnlineFinalForm" date="2003-09-02"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-09"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">1080</numbering>
<numbering type="pageLast">1081</numbering>
</numberingGroup>
<correspondenceTo>Department of Neurology, University of Würzburg, Josef‐Schneider‐Str. 11, 97080 Würzburg, Germany</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:MDS.MDS10495.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="0"></count>
<count type="tableTotal" number="0"></count>
<count type="referenceTotal" number="13"></count>
<count type="wordTotal" number="1081"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Long‐term safety of botulinum toxin type A</title>
<title type="short" xml:lang="en">Letters to the Editor</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes">
<personName>
<givenNames>Markus</givenNames>
<familyName>Naumann</familyName>
<degrees>MD</degrees>
</personName>
<contactDetails>
<email normalForm="naumann@mail.uni-wuerzburg.de">naumann@mail.uni‐wuerzburg.de</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>A. Peter</givenNames>
<familyName>Moore</familyName>
<degrees>MD, FRCP</degrees>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="DE" type="organization">
<unparsedAffiliation>Department of Neurology University of Würzburg Würzburg, Germany</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="GB" type="organization">
<unparsedAffiliation>Department of Neuroscience Liverpool University Liverpool, United Kingdom</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="DE" type="organization">
<unparsedAffiliation>Department of Neurology University of Würzburg Würzburg, Germany</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af4" countryCode="GB" type="organization">
<unparsedAffiliation>Department of Neuroscience Liverpool University Liverpool, United Kingdom</unparsedAffiliation>
</affiliation>
</affiliationGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<!--Version 0.6 générée le 3-12-2015-->
<mods version="3.6">
<titleInfo lang="en">
<title>Long‐term safety of botulinum toxin type A</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Letters to the Editor</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Long‐term safety of botulinum toxin type A</title>
</titleInfo>
<name type="personal">
<namePart type="given">Markus</namePart>
<namePart type="family">Naumann</namePart>
<namePart type="termsOfAddress">MD</namePart>
<affiliation>Department of Neurology University of Würzburg Würzburg, Germany</affiliation>
<description>Correspondence: Department of Neurology, University of Würzburg, Josef‐Schneider‐Str. 11, 97080 Würzburg, Germany</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">A. Peter</namePart>
<namePart type="family">Moore</namePart>
<namePart type="termsOfAddress">MD, FRCP</namePart>
<affiliation>Department of Neuroscience Liverpool University Liverpool, United Kingdom</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre authority="originalCategForm">letter</genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2003-09</dateIssued>
<dateCaptured encoding="w3cdtf">2003-02-04</dateCaptured>
<dateValid encoding="w3cdtf">2003-02-28</dateValid>
<copyrightDate encoding="w3cdtf">2003</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="references">13</extent>
<extent unit="words">1081</extent>
</physicalDescription>
<relatedItem type="host">
<titleInfo>
<title>Movement Disorders</title>
<subTitle>Official Journal of the Movement Disorder Society</subTitle>
</titleInfo>
<titleInfo type="abbreviated">
<title>Mov. Disord.</title>
</titleInfo>
<subject>
<genre>article category</genre>
<topic>Letter to the Editor</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>18</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>9</number>
</detail>
<extent unit="pages">
<start>1080</start>
<end>1081</end>
<total>2</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">C21BADE2AD5AFC9C2C60103AF192D2D33091F69C</identifier>
<identifier type="DOI">10.1002/mds.10495</identifier>
<identifier type="ArticleID">MDS10495</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2003 Movement Disorder Society</accessCondition>
<recordInfo>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
<recordContentSource>WILEY</recordContentSource>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004132 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 004132 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:C21BADE2AD5AFC9C2C60103AF192D2D33091F69C
   |texte=   Long‐term safety of botulinum toxin type A
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024